Dr. T Mooko was a Doctoral fellow at the Department of Internal Medicine, University of the Free State (UFS) and graduated in 2024. He is was aslo affiliated with the Next Generation Sequencing (UFS-NGS) Unit and Division of Virology, UFS. His PhD study was funded by the Council of Scientific and Industrial Research (CSIR). His PhD research sought to address possible factors contributing to HIV-1 shedding into peritoneal dialysis effluent in end-stage kidney failure patients (ESKF). It was an open-label non-randomised pharmacokinetic study, which intended to help improve current antiretroviral therapy dosing guidelines and clinical practices to prioritise high-risk patients, improve care and reduce treatment costs in this ESKF patient population. He was previously a National Research Foundation (NRF) Intern at the UFS-NGS Unit (2019-2020) and a research assistant at the unit. His Master’s research involved in-vitro and pre-clinical studies on the mechanisms of cannabinoids in the treatment of Alzheimer’s disease. Part of his Master’s objectives were completed at the School of Natural Product Studies, Jadavpur University, Kolkata, India. It was funded by the collaboration between the Department of Science and Innovation (DSI), South Africa and the Ministry of Science and Technology, India.
